By Alexander Bueso
Date: Tuesday 14 Jul 2020
(Sharecast News) - Shares of US drug developer Rigel Pharmaceuticals shot higher on news that researchers at Imperial College were set to launch a clinical trial into the use of one of its existing treatments to help patients suffering from mild-to-moderate Covid-19 pneumonia from worsening.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 41.19 |
| Change Today | $ -0.64 |
| % Change | -1.53 % |
| 52 Week High | $50.96 |
| 52 Week Low | $15.83 |
| Volume | 351,669 |
| Shares Issued | 167.18m |
| Market Cap | $6,886m |
| RiskGrade | 262 |
| Time | Volume / Share Price |
| 15:59 | 100 @ $41.20 |
| 15:59 | 100 @ $41.20 |
| 15:59 | 700 @ $41.15 |
| 15:59 | 100 @ $41.16 |
| 15:59 | 100 @ $41.16 |
You are here: research